Hi {{lead.First Name:default=edit me}},

Is dependability the primary factor you consider in a research partner? Did you know that Gilead has trusted Sanguine to prospectively procure biospecimens on 50 studies? Our partnership has covered key research areas, including SLE and RA, as well as an onsite collection program directly with Gilead employees so you have ready access to healthy control blood draws. Clearly, we make a good team in implementing critical studies in humans.

Regardless of your pipeline stage (preclinical, translational, clinical) or disease indication you can customize the study size and scope to accelerate results with a prospective in-home collection or clinical site coordination, including:

  • Recallable patients with specific inclusion/exclusion criteria
  • Fresh collection, same-day delivery, and fast turnaround time
  • Leukopaks from patients with confirmed conditions, such as autoimmune disease
  • Preanalytical lab services (PBMC isolation, HLA typing, etc)

If you are contemplating a new study or would like to learn more for a future study, please respond directly to this email or schedule a time on my calendar.

Warm Regards,

Jenny Matusova
Research Consultant
Sanguine Bio | Massachusetts

Schedule a Meeting
| www.sanguinebio.com